Cleveland, Ohio, USA June, 2025: Fondazione Ricerca e Innovazione Cardiovascolare, the Lodi, Italy-based research foundation has announced the completion of patient enrolment for a trial evaluating the safety and effectiveness of Sirolimus-Coated Balloon (SCB) in comparison with the Drug-Eluting Stents. The trial has enrolled a total of 1,832 patients from Europe, Asia and South America […]
The post Key Cardiology Trial Reaches Milestone in Comparing Sirolimus Balloon to Drug-Eluting Stent first appeared on Business News Week.